All Speakers: 2014 to 2020
Find below all the speakers who have done us the honor to participate in the Prix Galien
| FIRST NAME | LAST NAME | FONCTION | CIE INSTITUTION | YEAR | SOURCE |
|---|---|---|---|---|---|
| Gil | Bashe | Managing Partner, Global Health | FINN PARTNERS | 2020 | Digital Health Webinar (July 27th 2020) |
| Alon | Iron | President & CEO, Co-founder | THERANICA | 2020 | Digital Health Webinar (July 27th 2020) |
| Milind | Kamkolkar | Chief Digital & Data Officer | CELLARITY | 2020 | Digital Health Webinar (July 27th 2020) |
| Angela | Radcliffe | R&D Practice Lead Founding Member, CoS, IEEE Global Initiative to Standardize Fairness in the Trade of Data Advisory Board Member to Startups Clinical Research Advocate | CAPGEMINI INVENT, Life Science | 2020 | Digital Health Webinar (July 27th 2020) |
| Tal | Wenderow | CEO | VOCALIS HEALTH | 2020 | Digital Health Webinar (July 27th 2020) |
| Roy | Wiesner | Managing Director | aMOON | 2020 | Digital Health Webinar (July 27th 2020) |
| Eugene | Kandel | CEO | Start-Up Nation Central | 2020 | Digital Health Webinar (Aug. 31, 2020) |
| Gil | Bashe | Managing Partner, Global Health | FINN PARTNERS | 2020 | Digital Health Webinar (Aug. 31, 2020) |
| Junaid | Bajwa | MD. Chief Medical Scientist | Microsoft | 2020 | Digital Health Webinar (Aug. 31, 2020) |
| Uri | Bettesh | CEO | Datos-Health | 2020 | Digital Health Webinar (Aug. 31, 2020) |
| Shwen | Gwee | PhD. VP and Head of Global Digital Strategy | Bristol Myers Squibb | 2020 | Digital Health Webinar (Aug. 31, 2020) |
| Amir | Kalali | MD. Life Science and Technology Leader | CNS Summit Founder | 2020 | Digital Health Webinar (Aug. 31, 2020) |
| Jane | Metcalfe | CEO. Neo.Life | Co-founder Wired magazine | 2020 | Digital Health Webinar (Aug. 31, 2020) |
| Zeke | Emanuel | Dr. Architect of Obamacare | 2020 | JEF Webinar (May. 18, 2020) | |
| Philippe | Douste-Blazy | Dr. Former Minister of Health in France and United Nations Under Secretary and Former Minister of French Foreign Affairs | French Minister | 2020 | JEF Webinar (May. 18, 2020) |
| Tomasz | Trafny | Rev. Msgr. Head of Science and Faith Department Pontifical Council for Culture, Vatican General Secretary Science and Faith | STOQ Foundation | 2020 | JEF Webinar (May. 18, 2020) |
| Robin | Smith | Dr. President and Chairperson | Cura Foundation | 2020 | JEF Webinar (May. 18, 2020) |
| Andrew | C. von Eschenbach | Previous Commissioner of Department of Health and Human Services and Director | National Cancer Institute | 2020 | JEF Webinar (June. 15, 2020) |
| Amy | Abernethy | Principal Deputy Commissioner, Immediate Office of the Commissioner | U.S. Food and Drug Administration | 2020 | JEF Webinar (June. 15, 2020) |
| Joe | Grogan | Former Assistant to the President, Director of the Domestic Policy Council | The White House | 2020 | JEF Webinar (June. 15, 2020) |
| Murray "Mac" | Lumpkin | Deputy Director, Integrated Development (Lead for Global Regulatory Systems Initiatives), Bill & Melinda Gates Foundation; Prior Director of the Anti-Infective Drug Division; Prior Deputy Director of CDER and Former Deputy Commissioner of the International Programs of the FDA | Bill & Melinda Gates Foundation | 2020 | JEF Webinar (June. 15, 2020) |
| Michel | Sidibe | Minister of Health, Mali | African Medicines Agency | 2020 | JEF Webinar (June. 15, 2020) |
| Michael | Rosenblatt | MD, Chief Medical Officer | Flagship Pioneering | 2020 | JEF Webinar (July. 13, 2020) |
| Tal | Zaks | MD, PhD, Chief Medical Officer of | Moderna Therapeutics | 2020 | JEF Webinar (July. 13, 2020) |
| Max | Gomez | PhD, Senior Medical Correspondent | CBS2 New York | 2020 | JEF Webinar (August. 17, 2020) |
| Margaret | A. “Peggy” Hamburg | MD, Former Foreign Secretary, National Academy of Medicine, Chair of the NTI | bio Advisory Group and Former Commissioner of the U.S. Food and Drug Administration | U.S. Food and Drug Administration | 2020 | JEF Webinar (August. 17, 2020) |
| Eric | Rubin | MD, PhD, Editor-in-Chief, New England Journal of Medicine, and Adjunct Professor of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health | Harvard T.H. Chan School of Public Health | 2020 | JEF Webinar (August. 17, 2020) |
| Williams | Michele A. | ScD, Dean of the Faculty of the Harvard T.H. Chan School of Public Health, and Angelopoulos Professor in Public Health and International Development, Harvard T.H. Chan School of Public Health and Harvard Kennedy School | Harvard T.H. Chan School of Public Health and Harvard Kennedy School | 2020 | JEF Webinar (August. 17, 2020) |
| Anna K. | Abram | Deputy Commissioner for Policy, Planning, Legislation and Analysis | FDA | 2018 | |
| Sarah | Akerman | M.D., Senior Medical Director | Alkermes | 2018 | |
| Charles | Albright | PhD, Chief Scientific Officer | Editas Medicine, Inc. | 2016 | |
| David | Altshuler | Dr | Massachussets General Hospital and Blood Institute | 2013 | |
| David | Anderson | PhD, Professor of Biology, Howard Hughes Medical Institute | California Institute of Technology | 2014 | |
| Douglas | Andrews | CEO and Director | Stravencon | 2012 | |
| Abel | Archundia | MBA, Global Head of IT & Digital Transformation | Bayer Pharmaceuticals | 2019 | |
| David | Artis | PhD, Director, Roberts Institute for Research in Inflammatory Bowel Disease | Weill Cornell Medical College | 2015 | |
| Hala | Audi | Head of Secretariat, UK Review on Antimicrobial Resistance Richard Axel, MD, Nobel Laureate, Co-Director, Kavli Institute for Brain Science, Columbia University Medical Center; Investigator | Howard Hughes Medical Institute | 2014-2016 | |
| Christopher | Austin | Director, National Center for Advancing Translational Sciences | National Institutes of Health | 2013 | |
| Richard | Axel | MD, Nobel Laureate; Co-Director, Kavli Institute for Brain Science | Columbia University Medical Center | 2014 2015 | |
| Peter | Bach | MD, Director, Center for Health Policy and Outcomes | Memorial Sloan-Kettering Cancer Center | 2017 | |
| John | Baldoni | PhD, Senior Vice President, DPU Head, ln Silico Discovery | GSK Pharmaceuticals | 2018 | |
| Corey | Bargmann | PhD | The Rockefeller University | 2014 | |
| José | Baselga | MD, PhD, Physician-in-Chief & Chief Medical Officer, Memorial Sloan Kettering Cancer Center,Director, Board of Directors | GRAIL, Inc. | 2017 | |
| Frank C. | Bennett | PhD, Senior Vice-President of Research | Ionis Pharmaceuticals | 2017 | |
| Jeffery | Berkowitz | SVP Pharmaceutical Development and Market Access | Walgreens | 2011 | |
| Emily | Bernstein | PhD, Professor | Ivahn School of Medicine at Mount Sinai | 2014 | |
| Kathie M. | Bishop | PhD, Chief Scientific Officer | Otonomy | 2017 | |
| Cheryl R. | Blanchard | PhD, CEO, MicroCHIPS | Biotech, Inc. | 2015 | |
| Carina | Blomström-Lundqvist | PhD, Professor of Cardiology | Uppsala University, Sweden | 2017 | |
| Jeff | Bluestone | Professor, Head, Diabetes Center, and Provost | UCSF | 2014 | |
| Michael | Bonney | Partner | Third Rock Ventures, LLC | 2016 | |
| Alexis | Borisy | Partner | Third Rock Ventures | 2018 | |
| Albert | Bourla | DVM, PhD, Chief Executive Officer | Pfizer | 2019 | |
| Marc M. | Boutin | JD, Chief Executive Officer | National Health Council | 2018 | |
| Karin | Briner | PhD, Vice President & Head, Global Discovery Chemistry | Novartis | 2019 | |
| Michael S. | Brown | Professor & Director, Jonsson Center for Molecular Genetics | UT Southwestern Medical Center, Dallas | 2011 2013 2014 | |
| Paula | Brown Stafford | M.Ph., Chief Development Officer, Novan, Inc. & Adjunct Professor of Public Health Leadership | University of North Carolina, Chapel Hill, Co-Founder of Habergeon LLC | 2018 | |
| Samantha | Budd | Dr, Vice President, Neuroscience iMed, | AstraZeneca R&D | 2013 | |
| Jaime | Burnes | Managing Director, Healthcare Investment Banking | Cowen Group | 2011 | |
| Amy K. | Butler | PhD, President of Biosciences | Thermo Fisher Scientific | 2019 | |
| Sean | Caffey | MD, MBA, Co-Founder, Chairman & CEO, Auricle, LLC; Co-Founder & Chairman | Replenish, Inc. | 2015 | |
| Robert M. | Califf | Dr, Vice Chancellor for Clinical and Translational Medicine Director of Duke Translational Medicine Institute (DMTMI) and Professor of Medicine in the Division of Cardiology Duke University | 2013 | ||
| John | Camm | MD, Professor of Clinical Cardiology | St George’s, University of London | 2017 | |
| John | Castellani | President & Chief Executive Officer | Pharmaceutical Research and Manufacturers of America (PhRMA) | 2012 | |
| Satty | Chandrashekhar | Managing Director and Partner | Boston Consulting Group | 2019 | |
| Paul | Chew | Dr, Sr Vice President, CSOCMO | Sanofi Aventis | 2010 | |
| Alessio | Ciulli | PhD, Professor of Chemical & Structural Biology, School of Life Sciences | University of Dundee | 2019 | |
| Ron | Cohen | Dr, President and CEO | Acorda Therapeutics | 2010 | |
| Rory | Collins | FRS, FMedSci, Head, Nuffield Department of Population Health and BHF Professor of Medicine and Epidemiology | University of Oxford | 2014 | |
| Meryl | Comer | President | Geoffrey Beene Foundation Alzheimer’s Initiative | 2012 | |
| Craig | Crews | PhD, Founder and Chief Scientific Officer | Arvinas | 2019 | |
| Glenn | D. Steele | Jr., MD, PHD, President and CEO | Geisinger Health System | 2015 | |
| Stephen | Daniels | MD, PhD, MPH, Professor and Chair, Department of Pediatrics | University of Colorado | 2011 | |
| Alice | Dautry | Ph.D., Director, General | Institut Pasteur | 2012 | |
| Brett | Davis | Senior Director, Personalized Healthcare, Health Sciences Global Business Unit | Oracle Corporation | 2011 | |
| Geraldine | Dawson | PhD, Professor & Director, Duke Center for Autism and Brain Development | Duke University Medical Center | 2015 | |
| Neil | De Crescenzo | SVP and General Manager | Oracle Health Sciences | 2012 | |
| Darryl | De Vivo | MD, Sidney Carter Professor of Neurology and Pediatrics | Columbia University Medical Center | 2017 | |
| Glen | De Vries | President, Medidata Solutions Worldwide | Medidata Solutions, Inc. | 2014-2016 | |
| Karl | Deisseroth | MD, PhD, Chen Professor | Stanford University | 2014 | |
| George D. | Demetri | M.D., Senior Vice President for Experimental Therapeutics, Dana-Farber Cancer Institute; Professor of Medicine & Director, Ludwig Center, Harvard Medical School; Associate Director for Clinical Sciences, Dana-Farber | Harvard Cancer Center | 2018 | |
| Alex | Depaoli | MD, Vice President of Translational Research | NGM Biopharmaceuticals | 2011 | |
| Nancy-Ann | Deparle | JD, Partner | Consonance Capital Partners | 2015 | |
| Susan | Desmond-Hellmann | MD, MPH, Chief Executive Officer | Bill & Melinda Gates Foundation, Prix Galien USA Committee Chair | 2018 2019 | |
| Marc | Diamond | MD, Distinguished Chair in Basic Brain Injury and Repair and Director, Center for Alzheimer’s and Neurodegenerative Disease | University of Texas, Southwestern Medical Center | 2017 | |
| Sir Andrew | Dillon | Chief Executive | National Institute for Health and Care Excellence (NICE), UK | 2018 | |
| Mikael | Dolsten | MD, PhD, Chief Scientific Officer & President, Worldwide Research, Development and Medical (WRDM) | Pfizer | 2013 2014 2016 2017 2018 2019 | |
| William | Doyle | MBA, Executive Chair, NovoCure, Ltd.; Co-Founder & Managing Partner, WFD Ventures LLC; Member | Pershing Square Capital, LP | 2015 | |
| Nancy | Dreyer | PhD, MPH, FISPE, Fellow DIA, Chief Scientific Officer | IQVIA | 2019 | |
| Daniel | Drucker | MD, Senior Scientist, Lunenfeld Tanenbaum Research Institute | Mount Sinai Hospital, Toronto, Ontario | 2016 | |
| Paul | Eisenberg | Dr, Sr Vice President, Global Regulatory Affairs and Safety | Amgem | 2010 | |
| Ezekiel | Emmanuel | MD, PhD, Vice Provost for Global Initiatives & Chair, Medical Ethics and Health Policy Levy, Perelman School of Medicine & Wharton School | University of Pennsylvania | 2014 | |
| David R. | Epstein | MBA, Executive Partner, Flagship Pioneering | Flagship Pioneering | 2016 2019 | |
| Robert S. | Epstein | M.D., Chief Clinical Research and Development Officer | Medco Health Solutions, Inc. | 2011 | |
| Mark | Feinberg | MD, PhD, President and CEO | The International AIDS Vaccine Initiative (IAVI) | 2017 | |
| David | Feltquate | MD, PhD, Vice President, Immuno- Oncology | Bristol-Myers Squibb | 2016 | |
| Adolfo | Ferrando | MD, PhD, Professor, Institute for Cancer Genetics | Columbia University Medical Center | 2014 | |
| Mauro | Ferrari | Ph.D., Chair, Ernest Cockrell Jr. Presidential Distinguished Chair, President and Chief Executive Officer, Houston Methodist Research Institute, Executive Vice President | Houston Methodist Hospital System | 2018 | |
| Michael | Fischbach | Ph.D., Associate Professor of Bioengineering | Stanford University | 2018 | |
| Martin | Fitchet | MD, Chief Operating Officer, Pharmaceutical Research & Development | Johnson & Johnson, | 2011 | |
| Emmanuel | Fombu | MD, MBA, Physician, Author: The Future of Healthcare | 2019 | ||
| Jean Francois | Formela | MD, Partner | Atlas Ventures | 2017 | |
| Richard | Foster | PhD, Venture Partner, Lux Capital; Special Advisor for Health Innovation, Yale University; Director Emeritus | McKinsey & Co. | 2014 | |
| Jacqualyn | Fouse | PhD, Chief Executive Officer | Agios | 2019 | |
| Kenneth C. | Frazier | JD, CEO and Chairman | Merck & Co. Inc. | 2013 2015 | |
| O.H. (Bud) | Frazier | MD, Chief of Cardiopulmonary Transplantation, Program Director and Chief, Center for Cardiac Support, and Director of Cardiovascular Surgery Research, Texas Heart Institute; Chief of Transplant Service | St. Luke’s Episcopal Hospital | 2015 | |
| Maria C. | Freire | PhD, President & Executive Director | Foundation for the National Institutes of Health | 2012 2016 | |
| Jeffrey | Friedman | MD, PhD, Marilyn M Simpson Professor, Investigator Howard Hughes Medical Institute, Laboratory of Genetics | The Rockefeller University | 2011 | |
| Maria | Friere | PhD, President & Executive Director | Foundation for the National Institutes of Health | 2016 | |
| Les | Funtleyder | Fund manager | Polliwog | 2011 2012 | |
| John | Furey | Chief Operating Officer | Spark Therapeutics Inc. | 2018 | |
| Julie | Gerberding | M.D., MPH, President, Merck Vaccines, Former Director | Merck & Co Inc, Disease Control and Prevention (CDC) | 2012 | |
| Barry | Gertz | MD, PhD., SVP, head of clinical research and regulatory affairs | Merck | 2011 | |
| Walter | Gilbert | PhD, Nobel Laureate | Harvard University | 2011 | |
| Michael | Giordano | MD, Senior Vice President & Head of Development, Oncology and Immunoscience | Bristol-Myers Squibb | 2014 | |
| Laurie H. | Glimcher | MD, Dean & Professor | Weill Cornell Medical College | 2014 2015 | |
| Laurie | Glimcher | Pr, Cornell Provost for Medical Affairs and Dean | Medical College, New York | 2013 | |
| Joseph | Goldstein | Nobel Laureate, Professor of Molecular Genetics & Internal Medicine | UT Southwestern Medical Center at Dallas | 2011 2013 2014 | |
| Jeffrey I. | Gordon | MD, Professor and Director, Center for Genome Sciences and Systems Biology | Washington University, St. Louis | 2015 | |
| Alex | Gorsky | Chairman and CEO | Johnson & Johnson | 2013 | |
| Scott | Gottlieb | MD, Former Commissioner | U.S. FDA | 2019 | |
| Maria | Grazia Roncarolo | MD, Professor of Pediatrics and Medicine | Stanford University School of Medicine | 2019 | |
| Paul | Greengard | PhD, Nobel Laureate | Rockefeller University | 2010 2011 | |
| Philip D. | Gregory | Ph.D., Chief Scientific Officer | Bluebird | 2018 | |
| Scott | Grundy | Center for Human Nutrition | UT Southwestern Medical Center | 2014 | |
| Kimberly | Ha | Global Editor | Biopharm Insight | 2011 2012 | |
| William | Hait | MD, PhD, Global Head, R&D | Janssen R&D | 2014 | |
| John E. | Hambor | PhD, Director of Research Beyond Borders | Boehringer Ingelheim | 2015 | |
| Margaret | Hamburg | MD, Former Commissioner | U.S. Food and Drug Administration | 2012 2015 2016 | |
| Patrice A. | Harris | M.D., M.A., President-elect | American Medical Association | 2018 | |
| Fred | Hassan | M.D. | P. Roy Vagelos | 2012 | |
| Richard | Hatchett | MD, CEO | The Coalition for Epidemic Preparedness Initiative (CEPI) | 2017 | |
| Michael | Heffernan | Chairman | Collegium Pharmaceutical | 2018 | |
| Thomas | Heffner | Dr, Executive Director of Worlwide Business Development | Pfizer | 2010 | |
| Karl | Hick | Chief Digital and Information Officer | Takeda | 2019 | |
| Kathy | High | MD, President and Head of R&D | Spark Therapeutics | 2019 | |
| Kathy | High | President and head of Research and Development | Spark Therapeutics | 2018 | |
| R.T. (Terry) | Hisey | Vice Chairman & US Life Sciences Leader | Deloitte LLP | 2012 | |
| David | Holtzman | Dr, Andrew B. And Gretchen P. Jones Professor and Chairman of Neurology, Professor of Developmental Biology, Associate Director Alzheimer's Disease Research Center | Washington University | 2013 | |
| Peter | Honing | Dr, Head Global Regulatory Affairs | Astra Zeneca | 2010 | |
| Herve | Hoppenot | President Novartis Oncology | Novartis Pharmaceuticals Corporation | 2013 | |
| Scott | Howell | M.D., M.B.A., Vice-President and Head, US Market Access | Novartis Pharmaceuticals Inc. | 2018 | |
| Clifford | Hudis | MD, CEO | American Society of Clinical Oncology | 2016 | |
| Mark | Hulse | RN, Vice President Information Technology and Chief Information Officer | Moffitt Cancer Center | 2011 | |
| Stephen | Hume | M.D., a leading clinician and a patient with early onset Alzheimer’s disease | 2012 | ||
| Andrew | Jack | Moderator | Financial Times | 2012 | |
| Sanchin | Jain | MD, MBA, Chief Medical Information &Innovation Officer, Merck & Co.; Lecturer | Harvard Medical School | 2014 | |
| Joanne | Jiang | Co-founder | Fountain Medical Development | 2012 | |
| Kris | Joshi | PhD, Global Vice President | Healthcare Oracle Health Sciences | 2012 2013 | |
| Carl H. | June | Dr, Director of Translational Research at the Abramson Cancer Center | University of Pennsylvania | 2013 | |
| Kenneth | Kaitin | Dr, Director | Tufts Center for the Study of Drug Development | 2010 | |
| Eric | Kandel | PhD, Nobel Laureate, Professor and Fred Kavli Professor, Department of Neuroscience | Columbia University, New York | 2010 2011 2017 | |
| Brian | Kaspar | Ph.D., Scientific Founder and Chief Scientific Officer | AveXis, Inc. | 2018 | |
| Russell | Katz | M.D., Director, Division of Neurology Products, Center for Drug Evaluation and Research | U.S. Food and Drug Administration | 2012 | |
| Mark | Kessel | Managing Directory | Symphony Capital LLC | 2010 | |
| Kostas | Kidos | Vice President, Safety and PV Strategy | Oracle Corporation | 2010 | |
| David | Koch | Institute Professor | Massachusetts Institute of Technology | 2018 | |
| Jean-Pierre A. | Kocher | Ph.D. Head, The Bioinformatics Core (BIC) | Mayo Clinic | 2012 | |
| Adrian R. | Krainer | PhD, St. Giles Foundation Professor of Molecular Genetics, Program Chair, Cancer & Molecular Biology | Cold Spring Harbor Laboratory, Watson School of Biological Sciences | 2017 | |
| Jörg | Kreuzer | Therapeutic Area Head Medicine CV | Boehringer Ingelheim Pharma GmbH & Co. KG | 2017 | |
| William | Kridel | Partner | Ferghana Partners | 2011 2012 | |
| Mark | Kris | Dr, Chief, Thoracic Oncology Services | Memorial Sloan Kettering Cancer Center, New York | 2013 | |
| Jim | Krueger | MD, PhD, Laboratory for Investigative Dermatology | Rockefeller University | 2017 | |
| Story | Landis | PhD, Chair, Former Director | National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH), and Co-Founder, NIH BRAIN Initiative | 2017 | |
| Robert S. | Langer | M.D., Ph.D., Chair, | Massachusetts Institute of Technology | 2015 2018 | |
| Stanley N. | Lapidus | President, CEO, and Co-Founder | SynapDx Corporation | 2014-2016 | |
| Martin | Leach | Chief Information Officer | Broad Institute, MIT and Harvard | 2012 | |
| John | Lechleiter | Dr, Chairman, and CEO | Eli Lilly & Company | 2013 | |
| Jonathan | Leff | MBA, Partner | Deerfield Institute | 2016 | |
| Jeffrey | Leiden | Dr, Chairman, President and CEO | Vertex | 2013 | |
| John | Leonard | MD, Chief Medical Officer | Intellia Therapeutics, Inc. | 2016 | |
| Richard A. | Lerner | M.D | Scripps Research Institute | 2011 | |
| Nick | Leschly | MBA, President and CEO | Bluebird Bio, Inc. | 2015 | |
| Richard | Lifton | Dr, Professor | Yale University School of Medicine | 2013 | |
| Rodolfo R. | Linas | Pr, MD, PhD, Chairman, Department of Physiology & Neuroscience | New York University | 2010 | |
| Dan R. | Littman | MD, PhD, Investigator, Howard Hughes Medical Institute Kimmel Professor of Molecular Immunology Skirball Institute of Biomolecular Medicine | New York University School of Medicine | 2017 2018 | |
| Donald | Lloyd-Jones | Chairman, Department of Preventative Medicine | Northwestern University | 2014 | |
| Peter D. | Loftus | Dow Jones Newswires reporter covering pharmaceutical industry; contributor | Wall Street Journal | 2011 | |
| Roger | Longman | Moderator | 2011 2012 | ||
| Julie | Louise Gerberding | MD, MPH, Chair, Executive Vice-President, Chief Patient Officer and Head of Policy, Communications, and Population Health | Merck & Co., Inc. | 2017 | |
| Jan | Lundberg | Dr, Executive Vice President, Science and Technology and President | Lily Research Labs, Lilly & Co | 2013 | |
| Charles R. | Mackay | PhD, Chief Scientific Officer, Inflammation and Immunology Research Unit | Pfizer, Inc. | 2015 | |
| Sandy | Macrae | PhD, President & CEO, Sangamo | BioSciences | 2016 | |
| Joel S. | Marcus | Executive Chairman & Founder, Alexandria Real, Estate Equities, Inc. Alexandria Venture Investments; Co-Founder, Alexandria Summit | Alexandria | 2012 2013 2014 2015 2016 2017 2018 2019 | |
| Michael | Mark | PhD, Vice President& Global Head, Cardio Metabolic Diseases Research | Boehringer Ingelheim | 2016 | |
| Peter | Marks | MD, PhD, Director, Center for Biologics Evaluation and Research (CBER) | U.S. FDA | 2018 2019 | |
| Lynn | Marks | M.D., Senior Vice President, Medicines Development Center for Infectious Diseases | GlaxoSmithKline plc | 2012 | |
| Paul A. | Marks | Dr, President, Emeritus, Laboratory Head of Cell Biology | Memorial Sloan Kettering Cancer Center, New York | 2011 2013 | |
| Sarkis K. | Mazmanian | PhD, Luis B. and Nelly Soux Professor of Microbiology | California Institute of Technology (Caltech) | 2015 2018 | |
| Corey | Mccann | M.D., Ph.D., President and Chief Executive Officer | Pear Therapeutics | 2018 | |
| Mark | Mcclellan | MD, PhD, Director, Duke-Robert J. Margolis Center for Health Policy | Duke University | 2014 2016 | |
| John | Mcmurray | MD, Professor, Institute of Cardiovascular and Medical Sciences | University of Glasgow | 2015 | |
| Ira | Mellman | Dr, Vice President, Research Oncology | Genentech | 2013 | |
| Steve | Miller | MD, Senior Vice President and Chief Medical Officer | Express Scripts | 2017 | |
| Gerard | Nahum | M.D., Vice President, Global Clinical Development for Medical Devices & eHealth, | Bayer Pharmaceuticals | 2018 | |
| Ameet | Nathwani | MBBS, MRCP, Senior Vice President and Global Head of Medical Affairs | Novartis | 2015 | |
| Lee N. | Newcomer | M.D., Principal, Lee Newcomer Consulting LLC; Former Senior Vice President, Oncology and Genetics | UnitedHealthcare | 2018 | |
| William | Newsome | PhD, Professor | Stanford University | 2014 | |
| Steven | Nissen | M.D., M.A.C.C., Chairman, Department of Cardiovascular Medicine Cleveland Clinic Foundation and Professor of Medicine, Cleveland Clinic Lerner School of Medicine at Case Western Reserve U. | Cleveland Clinic Foundation, Cleveland Clinic Lerner School of Medicine | 2011 | |
| Larry | Norton | MD, Deputy physician-in-chief for breast cancer programs and medical director, Evelyn H. Lauder Breast Center | Memorial Sloan-Kettering Cancer Center | 2011 | |
| Tara | Nuala | MD, FACC, Moderator & Medical Constributor | CBS This Morning | 2014 | |
| Stephen N. | Oesterle | MD, Senior Vice President of Medicine and Technology | Medtronic | 2015 | |
| Joshua J. | Ofman | MD, MSHS, Chief of Corporate Strategy and External Affairs | GRAIL | 2019 | |
| Bernat | Olle | Ph.D., Chief Executive Officer | Vedanta Biosc | 2018 | |
| Ülo | Palm | MD, PhD, MBA, Senior Vice-President, Digital Sciences | Allergan | 2019 | |
| Ed | Park | Executive Vice President 7 COO | Athenahealth, Inc. | 2014 | |
| Roy | Parker | PhD, Professor Cech-Leinwand Endowed Chair of Biochemistry | University of Colorado, Boulder | 2017 | |
| Steven | Paul | MD, President and CEO | Voyager Therapeutics | 2015 | |
| Steve | Pearson | MD, Founder and President | Institute for Clinical and Economic Review (ICER) | 2017 | |
| Magnus | Persson | MD, PhD, Managing Partner | The Column Group | 2011 | |
| Jennifer | Petter | PhD, Chief Scientific Officer | Arrakis | 2019 | |
| Seth | Pinsky | President, | New York City Economic Development Corporation (NYCEDC) | 2010 | |
| Gary | Pisano | Ph.D., Harry E. Figgie Professor of Business Administration | Harvard Business School | 2018 | |
| Peter J. | Pitts | President | Center for Medicine in the Public Interest | 2011 | |
| William | Potter | M.D., Ph.D., Senior Advisor | National Institute of Mental Health | 2012 | |
| Richard | Pr, Nobel Laureate, Co-Director, The Kavli Institute For Brain Science | Columbia University Medical Center, New York | 2013 | ||
| Stanley | Prusiner | MD, Chair, Nobel Laureate, Professor of Neurology and Biochemistry | University of California, San Francisco (UCSF) | 2017 | |
| Mark | Pykett | President and Chief Executive Officer | Neoprobe Corporation | 2011 | |
| Paul I. | Rachlin | Partner | Proskauer | 2011 | |
| Daniel | Rader | Professor of Medicine | University of Pennsylvania | 2014 | |
| Guido | Rasi | Executive Director | European Medicines Agency | 2012 | |
| Vivek | Reddy | MD, Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology, | Icahn School of Medicine, Mount Sinai | 2017 | |
| Robert H | Ring | hD, Chief Science Officer | Autism Speaks | 2015 | |
| Michael | Ringel | JD, PhD, Senior Partner & Managing Director | BCG | 2019 | |
| Michael | Ringel | PhD, JD, Senior Partner & Managing Director | BCG | 2018 | |
| Maryanne | Rizk | PhD, Senior Vice President Digital R&D Strategy | IQVIA | 2019 | |
| Kent | Rogers | M.B.A., Senior Vice President, Industry Relations | UnitedHealth Group Inc. | 2018 | |
| Dana | Rollison | Ph.D., Vice President, Total Cancer Care and Chief Health Information Officer | Moffitt Cancer Center | 2011 | |
| Steve | Rosenberg | Senior Vice President & General Manager | Oracle Health Sciences | 2018 2019 | |
| Mike | Rosenblatt | MD, Chief Medical Officer | Flagship Pioneering | 2011 2012 2013 2018 2019 | |
| Hans | Rosling | Professor | Karolinska Institutet | 2014 | |
| Sergio | Rossi | MBA, Managing Director & Partner | Boston Consulting Group | 2019 | |
| John W. | Rowe | MD, Julius B. Richmond Professor of Health Policy and Aging, Mailman School of Public Health | Columbia University | 2015 | |
| Francesco | Rubino | MD, Associate Professor of Surgery, Director, Metabolic & Diabetes Surgery Center | Weill Cornell Medical College | 2011 | |
| Lars | Rydén | MD, Dr h.c., HMRCP, FESC, FACC, FAHA, Senior Professor of Cardiology | Karolinska Institute, Stockholm, Sweden | 2015 2016 2017 | |
| Michel | Sadelain | MD, PhD, Director, Center for Cell Engineering | Memorial Sloan Kettering Cancer Center | 2016 | |
| Bengt | Samuelsson | MD, PhD, Nobel Laureate, Former President, Karolinska Institute, Former Chairman, Nobel Foundation | Karolinska Institute, Nobel Foundation | 2011 2013 2014 2015 2016 2017 2019 | |
| Alfred | Sandrock | MD, PhD, Executive Vice-President and Chief Medical Officer | Biogen | 2017 | |
| Luca | Santarelli | MD, Former Senior Vice President, Head of Neuroscience, Ophthalmology & Rare Diseases (NORD), Roche Pharma Research & Early Development | Roche | 2015 | |
| Troy | Sarich | PhD, Global Head Janssen R&D Strategy | Janssen Research & Development | 2018 | |
| Nadeem | Sarwar | MRPharmS Ph.D., Senior Director – Head, Population Research & Head, Cardiovascular Genetics | Pfizer | 2012 | |
| George | Scangos | PhD, CEO | Biogen | 2014 | |
| David | Schenkein | MD, General Partner, Google Ventures; Executive Chairman of the Board & Former Chief Executive Officer, | Agios Pharmaceuticals | 2018 2019 | |
| Julie | Schiffman | MBA, Vice President, Global Business Analytics | Pfizer | 2018 | |
| Leonard | Schleifer | MD, PhD, Founder, President and CEO | Regeneron Pharmaceuticals | 2017 | |
| David | Schleifer | M.D., Chief Executive Officer | Agios Pharmaceuticals | 2017 | |
| Jim | Scholefield | MBA, Executive Vice President, Chief Information and Digital Officer | Merck & Co | 2019 | |
| Dennis | Selkoe | M.D., Co-Director, Center for Neurological Diseases, Brigham and Women’s Hospital, and Vincent and Stella Coates Professor of Neurologic Diseases | Harvard Medical School | 2012 | |
| Magnus | Settergren | MD, PhD, Assoc Prof and Interventional Cardiologist | Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden | 2019 | |
| Gaurav | Shah | President and Chief Executive Officer | Rocket Pharmaceuticals, Inc. | 2018 | |
| Jonathan | Sheldon | PhD, Global Vice President, Healthcare, Health Sciences Global Business Unit | Oracle | 2014 2015 2016 | |
| Jonhathan | Sheldon | Dr, Global Senior Director of Translational Medicine | Oracle Health Sciences | 2013 | |
| Morgan | Sheng | Dr, Vice President, Neuroscience | Genentech | 2013 | |
| Elliott | Sigal | Dr, Former Executive Vice President, Chief Scientific Officer and President, R&D | BMS | 2013 | |
| Jonathan | Silverstein | Partner | OrbiMed Advisors | 2010 2011 | |
| Laura | Slatkin | Founder and CEO, NEST Fragrances; Co-Founder and Board President | New York Collaborates for Autism | 2015 | |
| Robin L. | Smith | MD, MBA, Founder | Neostem and Cura Foundation | 2019 | |
| Reisa | Sperling | Dr, Professor of Neurology | Harvard Medical School Department of Neurology, Brigham and Women's Hospital | 2013 | |
| Richard | Staub | President of Research and Development Solutions | IQVIA | 2019 | |
| Steven | Stein | MD, Senior Vice President, US Clinical Development and Medical Affairs | Novartis Oncology | 2014 | |
| Scot | Stevens | Chief Information Officer, UPMC CancerCenter & UPCI, Director Personalized Medicine Technology, | UPMC | 2012 | |
| Eliane | Strosberg | MD., PhD. | 2012 | ||
| Lorenz | Studer | MD, Founding Director, Center for Stem Cell Biology | Memorial Sloan-Kettering Cancer Center | 2015 | |
| Anthony | Sun | Partner | Aisling Capital | 2012 | |
| Kevin | Tabb | MD, chief medical officer | Stanford Hospital & Clinics. | 2011 | |
| Marry | Tanner | Managing Director | Peter J. Solomon Company | 2010 | |
| Marc | Tessier-Lavigne | Chair, PhD, President, Professor Laboratory of Brain Development and Repair | The Rockefeller University, New York | 2014 2015 | |
| Marc | Tessier-Lavigne | Dr, President, Professor Laboratory of Brain Development and Repair | The Rockfeller University | 2013 | |
| William | Thies | M.D., Chief Medical and Scientific Officer | Alzheimer’s Association | 2012 | |
| John | Thomas Potts Jr | Dr, Distinguished Jackson Professor of Clinical Medecine, | Massachussets General Hospital and Harvard Medical School | 2013 | |
| Craig | Thompson | MD, President & CEO | Memorial Sloan Kettering Cancer Center | 2016 | |
| Nancy | Thornberry | Chair, Chief Executive Officer | Kallyope | 2018 | |
| Eric | Topol | MD, Executive Vice President and Chair, Innovative Medicine Scripps Research; Director & Founder, Scripps Research Translational Institute; Author, Deep Learning | 2019 | ||
| Olivia | Tournay Flatto | PhD, Executive Director | Pershing Square Sohn Cancer Research Alliance | 2014 | |
| Kevin J. | Tracey | MD, President and CEO | Feinstein Institute for Medical Research | 2015 | |
| Nathan | Turner | Co-Founder | Flatiron Health, Inc. | 2014 | |
| Stephen J. | Ubl | President and Chief Executive Officer | PhRMA | 2017 | |
| P. Roy | Vagelos | MD, Chair, Retired Chairman and CEO, Merck & Co., Inc. Chairman of the Board | Regeneron Pharmaceuticals, Inc. Committee Chairman | 2012 2013 2014 2015 2016 2017 | |
| Rajeev | Venkayya | MD, President, Vaccine Business Unit | Takeda Pharmaceutical Company, Ltd. | 2017 | |
| Philip | Vickers | PhD, Global Head of Research & Development | Shire plc | 2016 | |
| Chris | Viehbacher | CEO, Sanofi; Chairman | Genzyme | 2014 | |
| Jan T. | Vilcek | M.D | New York University School of Medicine | 2011 | |
| Bert | Vogelstein | Dr, Professor | Johns Hopkins School of Medicine | 2013 | |
| Robert | Vonderheide | MD, DPhil, Professor of Clinical Research, Perelman School of Medicine | University of Pennsylvania | 2014 | |
| Sihong | Wang | PhD, Professor | City University of New York City College | 2014 | |
| Ryan | Watts | PhD, CEO | Denali Therapeutics | 2015 2017 | |
| Christophe | Weber | PharmD, Representative Director, President & Chief Executive Officer | Takeda | 2019 | |
| Gerald | Weissmann | M.D, Committee Chairman | New York University School of Medicine | 2011 | |
| Robert M. | Wenham | MD, MS, FACOG, FACS, Principal Investigator, Total Cancer Care Programs of Gynecologic Oncology & Experimental Therapeutics | Moffitt Cancer Center | 2011 | |
| Steve | Whitehead | PhD, Senior Associate Scientist, Laboratory of Infectious Diseases | NIH National Institute for Allergies & Infectious Diseases | 2017 | |
| Elie | Wiesel | Pr, Honorary Member, Peace Nobel Laureate | Boston University | 2011 2012 2013 | |
| Ron | Winslow | Senior Medical and Health Care Writer | WSJ Deputy Editor, Health and Science | 2011 | |
| Amanda | Woerman | PhD, Assistant Professor of Neurology | Institute for Neurodegenerative Diseases, (UCSF) | 2017 | |
| Joanna | Wolkowski | MBA, Vice-President, Portfolio & Decision Analysis | Pfizer | 2019 | |
| George | Yancopoulos | MD, PhD, Chief Scientific Officer | Regeneron Pharmaceuticals | 2016 2017 | |
| Krishna | Yeshvant | MD, General Partner | Google Ventures | 2014 | |
| Jide | Zeitlan | CEO | Keffi Group | 2011 | |
| Elias | Zerhouni | MD, President, Global R&D | Sanofi | 2014 | |
| Feng | Zhang | PhD, W. M. Keck Career Development Professor of Biomedical Engineering | MIT | 2015 | |
| Bernard | Zinman | MD, Director, Leadership Sinai Centre for Diabetes | Mount Sinai Hospital, Toronto, Ontario | 2016 | |
| Huda | Zoghbi | Dr, Professor | Baylor College of Medicine | 2013 | |
| Lynne | Zydowsky | Chief Science Officer, Alexandria Real, Estate Equities, Inc. Alexandria Venture Investments; President and Co-Founder Alexandria Summit | Alexandria | 2011 2014 2015 2016 2017 2018 2019 |